{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:12:45Z","timestamp":1786119165737,"version":"build-2736575974"},"reference-count":77,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1097\/gco.0b013e3282f10e22","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T20:45:32Z","timestamp":1236199532000},"page":"529-535","source":"Crossref","is-referenced-by-count":24,"title":["Polycystic ovarian syndrome \u2013 prognosis and treatment outcomes"],"prefix":"10.1097","volume":"19","author":[{"given":"Roger","family":"Hart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210129","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bpobgyn.2004.05.001","article-title":"Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome","volume":"18","author":"Hart","year":"2004","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R2-5-20210129","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"ESHRE\/ASRM Rotterdam Consensus Meeting Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"R3-5-20210129","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"R4-5-20210129","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.fertnstert.2004.04.041","article-title":"Prevalence of polycystic ovaries and polycystic ovary syndrome in lesbian women compared with heterosexual women","volume":"82","author":"Agrawal","year":"2004","journal-title":"Fertil Steril"},{"key":"R5-5-20210129","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.bpobgyn.2006.04.006","article-title":"Polycystic ovarian syndrome \u2013 prognosis and outcomes","volume":"20","author":"Hart","year":"2006","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"Suppl 1","key":"R6-5-20210129","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.fertnstert.2006.03.013","article-title":"Prenatal growth restraint followed by catch-up of weight: a hyperinsulinemic pathway to polycystic ovary syndrome","volume":"86","author":"De Zegher","year":"2006","journal-title":"Fertil Steril"},{"key":"R7-5-20210129","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1093\/humrep\/deh329","article-title":"Flutamide-metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third- to fourth-generation OC reduces body adiposity","volume":"19","author":"Ibanez","year":"2004","journal-title":"Hum Reprod"},{"key":"R8-5-20210129","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1210\/jc.2006-1378","article-title":"Age at menarche: influences of prenatal and postnatal growth","volume":"92","author":"Sloboda","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R9-5-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.1740001","article-title":"Developmental origin of polycystic ovary syndrome \u2013 a hypothesis","volume":"174","author":"Abbott","year":"2002","journal-title":"J Endocrinol"},{"key":"R10-5-20210129","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/humupd\/dmi013","article-title":"Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?","volume":"11","author":"Abbott","year":"2005","journal-title":"Hum Reprod Update"},{"key":"R11-5-20210129","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0739-7240(02)00144-3","article-title":"In utero programming of sexually differentiated gonadotrophin releasing hormone (GnRH) secretion","volume":"23","author":"Robinson","year":"2002","journal-title":"Domest Anim Endocrinol"},{"key":"R12-5-20210129","first-page":"257","article-title":"Sexual differentiation of the brain of the sheep: effects of prenatal implantation of androgen. Film: general discussion","volume":"62","author":"Short","year":"1978","journal-title":"Ciba Found Symp"},{"key":"R13-5-20210129","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/humupd\/dmi025","article-title":"Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth","volume":"11","author":"Diamanti-Kandarakis","year":"2005","journal-title":"Hum Reprod Update"},{"key":"R14-5-20210129","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1210\/jcem-57-2-356","article-title":"Insulin resistance in nonobese patients with polycystic ovarian disease","volume":"57","author":"Chang","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"R15-5-20210129","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2265.1992.tb02909.x","article-title":"Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome","volume":"36","author":"Kiddy","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R16-5-20210129","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/humupd\/dmh018","article-title":"Improving reproductive performance in overweight\/obese women with effective weight management","volume":"10","author":"Norman","year":"2004","journal-title":"Hum Reprod Update"},{"key":"R17-5-20210129","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/humrep\/deg367","article-title":"Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet","volume":"18","author":"Crosignani","year":"2003","journal-title":"Hum Reprod"},{"key":"R18-5-20210129","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/humrep\/13.6.1502","article-title":"Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment","volume":"13","author":"Clark","year":"1998","journal-title":"Hum Reprod"},{"key":"R19-5-20210129","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.fertnstert.2004.02.104","article-title":"A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and\/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study","volume":"82","author":"Hoeger","year":"2004","journal-title":"Fertil Steril"},{"key":"R20-5-20210129","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/humrep\/14.9.2223","article-title":"Endocrine features of polycystic ovary syndrome in a random population sample of 14\u201316 year old adolescents","volume":"14","author":"van Hooff","year":"1999","journal-title":"Hum Reprod"},{"key":"R21-5-20210129","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/humrep\/deh079","article-title":"Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at 18 years","volume":"19","author":"van Hooff","year":"2004","journal-title":"Hum Reprod"},{"key":"R22-5-20210129","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/humrep\/deh207","article-title":"Polycystic ovary syndrome in adolescence \u2013 a therapeutic conundrum","volume":"19","author":"Homburg","year":"2004","journal-title":"Hum Reprod"},{"key":"R23-5-20210129","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1203\/00006450-199512000-00024","article-title":"Longitudinal change of sonographic ovarian aspects and endocrine parameters in irregular cycles of adolescence","volume":"38","author":"Venturoli","year":"1995","journal-title":"Pediatr Res"},{"key":"R24-5-20210129","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.1210\/jc.2004-0047","article-title":"Flutamide\u2013metformin plus ethinylestradiol\u2013drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide","volume":"89","author":"Ibanez","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R26-5-20210129","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1210\/jc.2004-1405","article-title":"Flutamide\u2013metformin plus ethinylestradiol\u2013drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of metformin at the start and after more than one year of therapy","volume":"90","author":"Ibanez","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R27-5-20210129","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1367\/A04-130R.1","article-title":"Overweight status of adolescent girls with polycystic ovary syndrome: body mass index as mediator of quality of life","volume":"5","author":"Trent","year":"2005","journal-title":"Ambul Pediatr"},{"key":"R28-5-20210129","doi-asserted-by":"crossref","first-page":"33S","DOI":"10.1016\/S0002-9343(99)80057-6","article-title":"Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of noninsulin-dependent diabetes mellitus","volume":"98","author":"Dunaif","year":"1995","journal-title":"Am J Med"},{"key":"R29-5-20210129","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0015-0282(16)54892-4","article-title":"Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones","volume":"57","author":"Dahlgren","year":"1992","journal-title":"Fertil Steril"},{"key":"R30-5-20210129","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R31-5-20210129","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"R32-5-20210129","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.atherosclerosis.2005.10.007","article-title":"Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives","volume":"185","author":"Cussons","year":"2006","journal-title":"Atherosclerosis"},{"key":"R33-5-20210129","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1385\/ENDO:30:1:45","article-title":"Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS","volume":"30","author":"Teede","year":"2006","journal-title":"Endocrine"},{"key":"R34-5-20210129","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2337\/dc06-0618","article-title":"Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome","volume":"30","author":"Meyer","year":"2007","journal-title":"Diabetes Care"},{"key":"R35-5-20210129","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1210\/jc.2005-0628","article-title":"Healthcare-related economic burden of the polycystic ovary syndrome during the reproductive life span","volume":"90","author":"Azziz","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R36-5-20210129","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bpobgyn.2004.05.007","article-title":"Hirsutism and acne in polycystic ovary syndrome","volume":"18","author":"Archer","year":"2004","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R37-5-20210129","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1067\/mob.2003.294","article-title":"A randomized controlled trial of second- versus third-generation oral contraceptives in the treatment of acne vulgaris","volume":"188","author":"Rosen","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R38-5-20210129","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1210\/jc.2003-031780","article-title":"Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: an open-labeled study","volume":"89","author":"Ganie","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R39-5-20210129","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/humrep\/16.5.940","article-title":"Does obesity diminish the positive effect of oral contraceptive treatment on hyperandrogenism in women with polycystic ovarian syndrome?","volume":"16","author":"Cibula","year":"2001","journal-title":"Hum Reprod"},{"key":"R40-5-20210129","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejogrb.2006.10.013","article-title":"Treatment of polycystic ovary syndrome with spironolactone plus licorice","volume":"131","author":"Armanini","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R41-5-20210129","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1507\/endocrj.52.299","article-title":"Endocrine and metabolic effects of rosiglitazone in nonobese women with polycystic ovary disease","volume":"52","author":"Dereli","year":"2005","journal-title":"Endocr J"},{"key":"R42-5-20210129","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1093\/humrep\/dei104","article-title":"Acarbose in obese patients with polycystic ovarian syndrome: a double-blind, randomized, placebo-controlled study","volume":"20","author":"Penna","year":"2005","journal-title":"Hum Reprod"},{"key":"R43-5-20210129","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.ijo.0801994","article-title":"Obesity and the polycystic ovary syndrome","volume":"26","author":"Gambineri","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"R44-5-20210129","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0015-0282(03)00265-6","article-title":"Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome","volume":"79","author":"Yildirim","year":"2003","journal-title":"Fertil Steril"},{"key":"R45-5-20210129","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S1472-6483(10)61182-0","article-title":"Effects of lifestyle modification in polycystic ovarian syndrome","volume":"12","author":"Moran","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"R46-5-20210129","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nature05488","article-title":"Abdominal obesity and metabolic syndrome","volume":"444","author":"Despres","year":"2006","journal-title":"Nature"},{"key":"R47-5-20210129","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/humrep\/dei311","article-title":"Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study","volume":"21","author":"Tang","year":"2006","journal-title":"Hum Reprod"},{"key":"R48-5-20210129","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1136\/bmj.38867.631551.55","article-title":"Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial","volume":"332","author":"Moll","year":"2006","journal-title":"BMJ"},{"key":"R49-5-20210129","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMoa063971","article-title":"Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome","volume":"356","author":"Legro","year":"2007","journal-title":"N Engl J Med"},{"key":"R50-5-20210129","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.fertnstert.2006.05.069","article-title":"Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction and achievement of pregnancy in 154 women with polycystic ovary syndrome","volume":"87","author":"Neveu","year":"2007","journal-title":"Fertil Steril"},{"key":"R51-5-20210129","first-page":"CD002249","article-title":"Oral antioestrogens and medical adjuncts for subfertility associated with anovulation.","volume":"1","author":"Beck","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"R52-5-20210129","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1093\/humrep\/del053","article-title":"Clomiphene citrate and dexamethazone in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective placebo-controlled study","volume":"21","author":"Elnashar","year":"2006","journal-title":"Hum Reprod"},{"key":"R54-5-20210129","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/humrep\/dei505","article-title":"Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: a randomized placebo-controlled study","volume":"21","author":"Rautio","year":"2006","journal-title":"Hum Reprod"},{"key":"R55-5-20210129","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.fertnstert.2006.05.061","article-title":"Rosiglitazone treatment alleviates inflammation and improves liver function in overweight women with polycystic ovary syndrome: a randomized placebo-controlled study","volume":"87","author":"Rautio","year":"2007","journal-title":"Fertil Steril"},{"key":"R56-5-20210129","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.fertnstert.2004.07.952","article-title":"Single-dose administration of an aromatase inhibitor for ovarian stimulation","volume":"83","author":"Mitwally","year":"2005","journal-title":"Fertil Steril"},{"key":"R57-5-20210129","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/humrep\/deg311","article-title":"Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility","volume":"18","author":"Mitwally","year":"2003","journal-title":"Hum Reprod"},{"key":"R58-5-20210129","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.fertnstert.2006.04.026","article-title":"Use of an aromatase inhibitor in patients with polycystic ovary syndrome: a prospective randomized trial","volume":"86","author":"Bayar","year":"2006","journal-title":"Fertil Steril"},{"key":"R59-5-20210129","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.fertnstert.2005.09.045","article-title":"Letrozole vs. clomiphene citrate in patients with ovulatory infertility","volume":"85","author":"Bayar","year":"2006","journal-title":"Fertil Steril"},{"key":"R60-5-20210129","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/j.1471-0528.2006.01034.x","article-title":"The influence of body weight on response to ovulation induction with gonadotrophins in 335 women with World Health Organization group II anovulatory infertility","volume":"113","author":"Balen","year":"2006","journal-title":"BJOG"},{"key":"R61-5-20210129","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1093\/humrep\/del265","article-title":"The use of a decremental dose regimen in patients treated with a chronic low-dose step-up protocol for WHO Group II anovulation: a prospective randomized multicentre study","volume":"21","author":"Hugues","year":"2006","journal-title":"Hum Reprod"},{"key":"R62-5-20210129","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/humrep\/dei501","article-title":"A systematic review and meta-analysis of randomized controlled trials on metformin co-administration during gonadotrophin ovulation induction or IVF in women with polycystic ovary syndrome","volume":"21","author":"Costello","year":"2006","journal-title":"Hum Reprod"},{"key":"R63-5-20210129","first-page":"CD001122","article-title":"Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome.","volume":"2","author":"Farquhar","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"R64-5-20210129","first-page":"439","article-title":"Comparison of 5-, 10-, and 15-point laparoscopic ovarian electrocauterization in patients with polycystic ovarian disease: a prospective, randomized study","volume":"9","author":"Tabrizi","year":"2005","journal-title":"JSLS"},{"key":"R66-5-20210129","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1210\/jc.2004-0689","article-title":"Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized double-blind placebo-controlled trial","volume":"89","author":"Palomba","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R67-5-20210129","first-page":"611","article-title":"Polycystic ovaries and ovarian hyperstimulation syndrome: a systematic review","volume":"84","author":"Tummon","year":"2005","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R68-5-20210129","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/humupd\/dmi036","article-title":"A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome","volume":"12","author":"Heijnen","year":"2006","journal-title":"Hum Reprod Update"},{"key":"R69-5-20210129","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1210\/jc.2006-1123","article-title":"Insulin resistance increases the risk of spontaneous abortion following assisted reproduction technology treatment","volume":"92","author":"Tian","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R70-5-20210129","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/humrep\/17.11.2858","article-title":"Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin","volume":"17","author":"Glueck","year":"2002","journal-title":"Hum Reprod"},{"key":"R71-5-20210129","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0015-0282(01)03202-2","article-title":"Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome","volume":"77","author":"Glueck","year":"2002","journal-title":"Fertil Steril"},{"key":"R72-5-20210129","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/humrep\/deh263","article-title":"Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy","volume":"19","author":"Glueck","year":"2004","journal-title":"Hum Reprod"},{"key":"R73-5-20210129","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1080\/09513590601010508","article-title":"Metformin reduces abortion in pregnant women with polycystic ovary syndrome","volume":"22","author":"Khattab","year":"2006","journal-title":"Gynecol Endocrinol"},{"key":"R74-5-20210129","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dml036","article-title":"A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome","volume":"12","author":"Boomsma","year":"2006","journal-title":"Hum Reprod Update"},{"key":"R75-5-20210129","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.fertnstert.2006.02.098","article-title":"Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis","volume":"86","author":"Gilbert","year":"2006","journal-title":"Fertil Steril"},{"key":"R76-5-20210129","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/humrep\/deh347","article-title":"Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study","volume":"19","author":"Vanky","year":"2004","journal-title":"Hum Reprod"},{"key":"R77-5-20210129","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/humupd\/dmi015","article-title":"Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome","volume":"11","author":"Checa","year":"2005","journal-title":"Hum Reprod Update"},{"key":"R78-5-20210129","first-page":"CD003053","article-title":"Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome.","volume":"2","author":"Lord","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"R79-5-20210129","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.2337\/diabetes.54.4.1150","article-title":"Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program","volume":"54","author":"Knowler","year":"2005","journal-title":"Diabetes"},{"key":"R80-5-20210129","first-page":"126","article-title":"Position Statement on Metabolic and Cardiovascular Consequences of Polycystic Ovary Syndrome.","volume":"11","year":"2005","journal-title":"Endocr Pract"}],"container-title":["Current Opinion in Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/GCO.0b013e3282f10e22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:42:34Z","timestamp":1786038154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001703-200712000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":77,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/gco.0b013e3282f10e22","relation":{},"ISSN":["1040-872X"],"issn-type":[{"value":"1040-872X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}